Unraveling the mystery of placebo effect in research and practice: An update

The placebo effect, observed when inert substances produce measurable health outcomes, has long intrigued researchers and clinicians. Traditionally attributed to psychological factors, recent evidence suggests neurobiological mechanisms may also contribute, though the exact pathways remain unclear. This review aims to provide an updated understanding of the placebo effect, exploring its underlying mechanisms, the factors influencing its variability, and its implications in both clinical research and practice. A comprehensive review of the literature was conducted, focusing on studies that examined psychological, genetic, and neurobiological contributions to the placebo effect. The review also considered the use of placebos in research, including their types, characteristics, and ethical considerations. Placebos can activate psychological mechanisms like expectation and conditioning, while neurobiological pathways involving the opioid and dopamine systems may also play a role. Genetic polymorphisms, such as those affecting the COMT enzyme, have been identified as potential predictors of placebo response. The scale of the placebo effect extends beyond subjective symptoms to physiological outcomes, including changes in heart rate, blood pressure, and brain activity. The placebo effect is influenced by multiple factors, including study design, disease type, and participant characteristics. High placebo response rates in certain conditions (e.g., pain, depression) raise questions about the reliability of test interventions. The ethical use of placebos, particularly in surgical and behavioral trials, remains a subject of debate. An improved understanding of placebo mechanisms is essential for optimizing its use in both research and clinical practice. Standardized reporting and ethical guidelines are necessary to ensure the integrity of placebo-controlled trials and the ethical application of placebo effects in patient care.